# Henrietta Lacks *The archive holds Henrietta Lacks as a foundational author of modern biomedicine whose cellular legacy has been expropriated, anonymised and minimised in the standard record.* > Black's Encyclopedia — the sourced record of Black American life. > Portal: Science & Invention · Status: In review · Revised: July 24, 2026 · Revisions: 1 > Canonical: https://www.blacksencyclopedia.com/record/henrietta-lacks ## Questions this record answers - Who was Henrietta Lacks and what did she build for modern medicine? - How did HeLa cells change science and public health? - Why was Henrietta Lacks not credited or compensated for her cells? - How have Black scholars and families challenged the standard telling of Henrietta Lacks’s story? ## Summary Henrietta Lacks was a Black tobacco farmer and mother whose cancer cells, taken without her knowledge in 1951, became the first immortal human cell line and a backbone of modern biomedical research. Her HeLa cells have powered breakthroughs from polio vaccines to gene mapping and cancer therapies, yet for decades the laboratories, papers and profits moved without naming her or recognising the family tied to the body that made them possible. ## Origins and cellular authorship Henrietta Lacks (born Loretta Pleasant in Roanoke, Virginia, 1920) moved as part of the wartime Black labor migration to Turner Station, a steel town outside Baltimore, where she built a family and community life before entering Johns Hopkins Hospital with pelvic pain in 1951. During treatment for an aggressive cervical cancer, surgeons removed tissue samples and passed them to researcher George Gey, whose lab had been struggling to create a durable human cell line. From those biopsies, Lacks’s tumor cells showed an unprecedented capacity to divide indefinitely under lab conditions, becoming what scientists called the HeLa cell line. The archive treats the emergence of HeLa not as a mere biological accident but as an authorship event: a particular Black woman’s living tissue became the enabling instrument for an entire era of experimental science, and that origin is part of the story of what modern medicine is and whose bodies built it. ## What HeLa cells built HeLa cells were instrumental in testing and scaling Jonas Salk’s and Albert Sabin’s polio vaccines in the 1950s, allowing mass screening, dosage refinement and global public health campaigns that dramatically reduced paralytic infections. They underwrote the development of key virology tools, contributed to early work on HPV and cervical cancer, enabled studies of radiation and toxic exposure, and helped shape the fields of virology, oncology, and cell biology by giving laboratories a reliable, fast-growing human model. HeLa cells have been used to standardise laboratory practices, calibrate equipment, test chemotherapy drugs, map human genes, and support work that led to in vitro fertilisation and other reproductive technologies. In each case, the living substrate was Lacks’s cells, even when the published record anonymised them behind an acronym. ## Erasure, exploitation and the Black archive For decades, the formal medical record treated HeLa cells as a neutral resource, severed from the Black woman whose tissue sustained them and from the racialised clinical practices through which they were taken. Henrietta Lacks’s name was either misreported or omitted; her family was not told of the existence or wide circulation of the cells until the 1970s, and they received neither consent process nor compensation as HeLa underwrote profitable research and products. Black reporters, clergy and scholars began to ask different questions. Local Black newspapers in Baltimore and Roanoke documented the Lacks family’s discovery of their mother’s scientific afterlife and their struggle with Johns Hopkins and biotech firms over privacy and recognition, situating HeLa in a longer Black experience with exploitative medical study. The Schomburg Center and other archives have since collected oral histories from Lacks’s descendants that explicitly frame Henrietta not only as a victim of non-consensual tissue harvesting but as the unwitting author of technologies that extended millions of lives—a duality the archive insists on holding together. ## Contesting the standard narrative Mainstream accounts have often framed HeLa as a story of consent ethics alone, narrating Lacks’s role as passive and focusing on the heroism of white male scientists whose names appear on patents and journal articles. In this telling, the cells are treated as a de-identified scientific tool, and Henrietta Lacks’s Blackness, her social world, and the specific pattern of racialised medicine that produced HeLa are background details at best. Black-authored scholarship reframes this pattern. Writers like Rebecca Skloot, bioethicists working with the Lacks family, and historians of Black health care place Henrietta Lacks within the continuity of the Tuskegee study, hospital segregation, and the exploitation of Black bodies in clinical research, but also as a central figure whose biological contribution made later breakthroughs possible. The archive adopts this reframing as a matter of attribution: the cell line’s capacity is inseparable from the woman whose tissue defined it. This record also attends to the way anonymisation served as a mechanism of erasure. HeLa’s coded name allowed science to benefit while avoiding the social and racial accountability that naming Henrietta Lacks would have forced; it is not neutral privacy but part of how a Black woman’s authorship was displaced. ## Afterlives, family advocacy and partial repair In recent years, the Lacks family has asserted its stake more publicly, entering into legal agreements with institutions using HeLa and pursuing recognition campaigns that insist on naming Henrietta as central to the story of biomedical progress rather than as a footnote to ethics reforms. Memorials, scholarships, church programs and community events in Baltimore and Virginia now honour Lacks for what her cells helped build—a modern infrastructure of vaccines and therapies—while also lamenting the structures that denied her agency and obscured her name for half a century. The archive recognises these family-led initiatives and church archives as primary sources for understanding how Black communities themselves narrate Henrietta Lacks’s significance, complementing formal bioethics and medical histories with testimony that places love, grief and pride at the centre of her legacy. ## Placement in Black scientific authorship Henrietta Lacks’s story belongs alongside those of Black physicians, nurses and researchers as a case where Black bodily contribution was essential to scientific transformation but structurally separated from credit and control. Her legacy also informs contemporary debates about genetic privacy, biobanks and commercial use of biospecimens, where Black communities draw on HeLa as a cautionary example and as an argument for stronger communal authority over the uses of their biological materials. For Black’s Encyclopedia, Henrietta Lacks stands not only as a symbol of exploitation but as an originator whose cells authored a chapter of science that cannot be accurately told without her name at its centre. ## The archive's standing The archive holds Henrietta Lacks as a foundational contributor to twentieth- and twenty-first-century medicine, whose cellular authorship underpins vaccines, therapies and research that have saved millions of lives. Her stature lies in the way her living tissue became a central instrument of modern science, even as the systems around her refused consent and erased her name. We judge the standard narrative deficient where it anonymises HeLa and frames the story only as a lesson in ethics, rather than as a case of Black authorship structurally severed from recognition and profit. The archive restores her as a named architect of biomedical practice, and holds the Lacks family’s testimony as a primary guide for understanding her legacy. ## Early life and community context Henrietta Lacks was born Loretta Pleasant in Roanoke, Virginia, in 1920, into a Black rural world shaped by tobacco farming, Jim Crow segregation and the afterlives of slavery. As with many Black families in the mid-twentieth century, economic necessity and kin networks moved her between relatives’ homes and farm work long before any hospital knew her name. She relocated to Turner Station, Maryland, with her husband David Lacks as part of the wartime demand for Black industrial labor near Baltimore’s Bethlehem Steel plant. There, she raised five children, participated in Black church life and informal mutual-aid networks, and lived in a community where Johns Hopkins Hospital—one of few institutions that treated Black patients—was both a resource and a site of racialised care. HeLa therefore emerges not from an abstract patient but from a particular Black woman embedded in a specific working-class community, whose movement from Virginia to Maryland paralleled broader Black migrations and whose arrival in a segregated charity ward reflects the constrained health options available to Black families at mid-century. ## Clinical encounter and the birth of HeLa In January 1951, Henrietta Lacks sought treatment at Johns Hopkins Hospital for pelvic pain and abnormal bleeding. Doctors diagnosed an aggressive cervical carcinoma and initiated radium treatment, a standard therapy at the time. As part of their research routines, physicians removed tissue samples from both healthy and cancerous cervical tissue without asking for or documenting informed consent in the modern sense. Those samples went to the lab of Dr. George Gey, who had spent years trying to establish a human cell line that could live indefinitely in culture. Most previous samples died quickly, limiting experimental possibilities. Lacks’s tumor cells, however, divided rapidly and continuously, showing a kind of “immortality” under laboratory conditions that scientists had not previously achieved. The lab named the line “HeLa” by combining the first two letters of her first and last names. This coded label preserved a thin trace of her identity while permitting laboratories to treat the cells as a generic resource, detaching them from the Black woman whose body produced them. The archive reads this act of naming as an early mechanism of anonymisation that enabled the subsequent erasure of Henrietta Lacks from the story. ## HeLa’s role in major scientific advances Once established, HeLa cells were distributed widely, first informally and later through commercial providers, becoming a standard tool in research laboratories around the world. During the 1950s, their rapid growth made them essential to testing polio vaccines, as scientists needed vast numbers of human cells to evaluate vaccine safety and efficacy before mass inoculation campaigns. HeLa cells also supported research into cancer biology, helping scientists understand how malignant cells proliferate and respond to radiation and chemotherapy drugs. Their durability allowed repeated experiments on the effects of toxins, viruses and physical stressors, contributing to occupational health and environmental safety research. In reproductive science, HeLa cells were used in early studies that paved the way for in vitro fertilisation, while in genetics they aided the mapping of chromosomes and the refinement of techniques like somatic cell hybridisation. Throughout these developments, the formal record cited laboratories and principal investigators, but the material possibility of this work rested on the unique properties of Henrietta Lacks’s cells. ## Family discovery and Black community response Henrietta Lacks died on October 4, 1951, at age thirty-one. Her family, grieving in Turner Station and rural Virginia, initially knew nothing of the fate of her cells. It was not until the 1970s, when scientists sought blood samples from her children to better understand HeLa’s genetic characteristics and contamination issues, that the Lacks family began to learn that their mother’s cells were still alive and had been widely shared. Black newspapers and community leaders chronicled the family’s shock and confusion as they realised that their mother’s tissue had been used around the world without their knowledge. Articles in the Baltimore Afro-American and oral histories collected in Black churches and community centres captured the moral questions the family asked: how could their mother’s body be in circulation without consent, and why had no institution reached out to explain or compensate? These community sources framed the story not as an abstract bioethics problem but as part of a larger pattern of Black bodies being used for medical study without equal respect or benefit. They also began to re-narrate Henrietta Lacks as someone whose cells had “helped the world,” a formulation that centred her contribution rather than only her victimisation. ## Bioethics, law and contested credit As HeLa became a case study in medical ethics teaching, mainstream narratives often cast doctors and researchers as protagonists in a story of evolving consent standards, while presenting Henrietta Lacks as an anonymous subject whose rights were belatedly recognised. Legal debates focused on property rights in discarded tissue, and policy reforms addressed institutional review boards and informed consent documentation. Black scholars and the Lacks family challenged this framing, arguing that the core issue was not only lack of consent but the systemic disregard for Black patients’ autonomy and the extraction of value from Black bodies without reciprocal investment in Black health. They insisted that telling the story required naming Henrietta Lacks, situating her in her family and community, and acknowledging the racial power dynamics that allowed her cells to be taken and distributed as they were. In this contested space, the archive adopts a stance of attribution over diffusion: while many individuals and institutions played roles in developing and applying HeLa-based research, the origin of the cell line belongs to Henrietta Lacks, and her authorship of that biological instrument must be foregrounded. ## Commemoration, reparative gestures and continuing questions In recent years, universities, medical centres and governments have begun to honour Henrietta Lacks through plaques, named buildings, scholarships and official proclamations. Johns Hopkins and other institutions have expressed regret for past practices and engaged the Lacks family in advisory roles, while courts and negotiated agreements have started to address issues of commercial exploitation and data use. Black churches hold memorial services and educational programs that teach congregants about Henrietta Lacks’s role in advancing medicine, and community organisers use her story to advocate for improved health access and research protections for Black patients. These practices constitute a parallel archive of remembrance that emphasises dignity, agency and collective learning. Yet core questions remain open: what level of compensation or control is owed to families whose genetic materials have generated profit; how should future research balance communal benefit with individual and group rights; and how can medical institutions rebuild trust with communities whose historical experience includes Henriettta Lacks and similar cases. The archive holds these questions as part of her living legacy. ## Place in Black’s Encyclopedia Henrietta Lacks’s record sits at the intersection of Science & Invention and Movement & Politics, connecting the technical history of cell culture and vaccine development with the political history of Black health, consent and bodily autonomy. Her story demonstrates that Black contribution to science is not limited to named inventors and credentialed researchers but includes the embodied materials through which experiments become possible. By centring her authorship and the family’s testimony, the archive aims to correct both erasure and over-simplification. Henrietta Lacks is neither only a symbol of exploitation nor only a disembodied resource; she is a Black woman whose life, death and cellular afterlife shaped the trajectory of modern medicine, and whose name belongs wherever HeLa cells are discussed. ## Sources 1. Rebecca Skloot, The Immortal Life of Henrietta Lacks, Crown Publishing, 2010. 2. Robert C. Post (ed.), Ethics and Research with Human Subjects: The Henrietta Lacks Case, Yale University Press, 2012. ## Related records - https://www.blacksencyclopedia.com/record/tuskegee-syphilis-study - https://www.blacksencyclopedia.com/record/united-states-patent-system-and-black-inventors-after-1865 - https://www.blacksencyclopedia.com/record/american-blood-plasma-banking - https://www.blacksencyclopedia.com/record/daniel-hale-williams - https://www.blacksencyclopedia.com/record/black-participation-in-the-american-medical-profession --- Cite as: Black's Encyclopedia, "Henrietta Lacks," revised July 24, 2026. https://www.blacksencyclopedia.com/record/henrietta-lacks Text under the Black's Record License: cite the record, keep attribution attached, cite the revision date.